EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

Shigeo Fuji, Takero Shindo

Stem Cell Investigation · 2016-10-31 · 3 · 70-70

DOI: 10.21037/sci.2016.09.13 ↗

At a glance

Übersichtsarbeit in Stem Cell Investigation, published online on 2016-10-31. Written by Shigeo Fuji and 1 co-authors. Institution: Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. Cited 43 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

Mogamulizumabadult T-cell leukemia/lymphoma (ATL/ATLL)graft-versus-host disease (GVHD)hematopoietic stem cell transplantationregulatory T cells (Tregs)

Authors and institutions

  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Hematology, Respiratory Medicine and Oncology, Saga University School of Medicine, Saga, Japan.

Cite

APA

Fuji, S., & Shindo, T. (2016). Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. Stem Cell Investigation, 3, 70-70. https://doi.org/10.21037/sci.2016.09.13

Vancouver

Fuji S, Shindo T. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. Stem Cell Investigation. 2016;3:70-70. doi:10.21037/sci.2016.09.13

BibTeX
@article{Fuji2016,
  author = {Fuji, Shigeo and Shindo, Takero},
  title = {Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma},
  journal = {Stem Cell Investigation},
  year = {2016},
  volume = {3},
  pages = {70--70},
  doi = {10.21037/sci.2016.09.13}
}
Start for free →